rs1050606

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001154.4(ANXA5):​c.-64T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.488 in 294,552 control chromosomes in the GnomAD database, including 35,812 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19448 hom., cov: 33)
Exomes 𝑓: 0.47 ( 16364 hom. )

Consequence

ANXA5
NM_001154.4 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.563

Publications

10 publications found
Variant links:
Genes affected
ANXA5 (HGNC:543): (annexin A5) The Annexin 5 gene spans 29 kb containing 13 exons, and encodes a single transcript of approximately 1.6 kb and a protein product with a molecular weight of about 35 kDa.The protein encoded by this gene belongs to the annexin family of calcium-dependent phospholipid binding proteins some of which have been implicated in membrane-related events along exocytotic and endocytotic pathways. Annexin 5 is a phospholipase A2 and protein kinase C inhibitory protein with calcium channel activity and a potential role in cellular signal transduction, inflammation, growth and differentiation. Annexin 5 has also been described as placental anticoagulant protein I, vascular anticoagulant-alpha, endonexin II, lipocortin V, placental protein 4 and anchorin CII. Polymorphisms in this gene have been implicated in various obstetric complications. [provided by RefSeq, Dec 2019]
ANXA5 Gene-Disease associations (from GenCC):
  • pregnancy loss, recurrent, susceptibility to, 3
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.554 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANXA5NM_001154.4 linkc.-64T>G 5_prime_UTR_variant Exon 1 of 13 ENST00000296511.10 NP_001145.1 P08758V9HWE0
ANXA5XM_017008141.3 linkc.-64T>G 5_prime_UTR_variant Exon 1 of 7 XP_016863630.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANXA5ENST00000296511.10 linkc.-64T>G 5_prime_UTR_variant Exon 1 of 13 1 NM_001154.4 ENSP00000296511.5 P08758

Frequencies

GnomAD3 genomes
AF:
0.500
AC:
76012
AN:
151944
Hom.:
19439
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.561
Gnomad AMI
AF:
0.615
Gnomad AMR
AF:
0.463
Gnomad ASJ
AF:
0.448
Gnomad EAS
AF:
0.269
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.413
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.499
GnomAD4 exome
AF:
0.474
AC:
67592
AN:
142492
Hom.:
16364
Cov.:
1
AF XY:
0.476
AC XY:
34324
AN XY:
72116
show subpopulations
African (AFR)
AF:
0.552
AC:
2475
AN:
4480
American (AMR)
AF:
0.449
AC:
1807
AN:
4022
Ashkenazi Jewish (ASJ)
AF:
0.446
AC:
2592
AN:
5818
East Asian (EAS)
AF:
0.209
AC:
2761
AN:
13214
South Asian (SAS)
AF:
0.404
AC:
518
AN:
1282
European-Finnish (FIN)
AF:
0.430
AC:
4495
AN:
10448
Middle Eastern (MID)
AF:
0.455
AC:
362
AN:
796
European-Non Finnish (NFE)
AF:
0.516
AC:
47777
AN:
92556
Other (OTH)
AF:
0.487
AC:
4805
AN:
9876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1651
3303
4954
6606
8257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.500
AC:
76056
AN:
152060
Hom.:
19448
Cov.:
33
AF XY:
0.491
AC XY:
36499
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.560
AC:
23260
AN:
41500
American (AMR)
AF:
0.462
AC:
7072
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
1554
AN:
3468
East Asian (EAS)
AF:
0.269
AC:
1379
AN:
5130
South Asian (SAS)
AF:
0.402
AC:
1937
AN:
4824
European-Finnish (FIN)
AF:
0.413
AC:
4377
AN:
10596
Middle Eastern (MID)
AF:
0.479
AC:
140
AN:
292
European-Non Finnish (NFE)
AF:
0.511
AC:
34737
AN:
67936
Other (OTH)
AF:
0.492
AC:
1040
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
2047
4094
6142
8189
10236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.508
Hom.:
2405
Bravo
AF:
0.508
Asia WGS
AF:
0.357
AC:
1244
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
7.5
DANN
Benign
0.63
PhyloP100
-0.56
PromoterAI
-0.021
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1050606; hg19: chr4-122618046; API